NAD (Nicotinamide Adenine Dinucleotide) therapy is often costly due to several factors tied to its complex production, strict compounding requirements, sensitive storage needs, and careful transport conditions.

1. Compounding and Purity Standards

• Complex Synthesis Process: NAD is a bioactive molecule that requires sophisticated synthesis. Ensuring high purity is crucial because impurities can reduce its effectiveness and safety, especially in IV applications.

• Quality Control and Testing: Pharmaceutical-grade NAD used in therapeutic settings is often required to meet stringent standards. The compounding process must be carefully managed to avoid degradation, which can involve additional quality control, potency, and stability testing.

• USP 797 Compliance: Facilities compounding NAD for IV use must often adhere to USP 797 guidelines for sterile preparation, requiring a sterile environment, trained personnel, and costly cleanroom setups, which add significant overhead.

2. Storage Requirements

• Stability Concerns: NAD is sensitive to environmental conditions. To retain efficacy, NAD typically requires refrigeration or even freezing, which increases storage costs in compounding pharmacies or facilities.

• Protection Against Degradation: Exposure to light, oxygen, and heat can degrade NAD, reducing its bioavailability. Specialized containers with UV protection, low-oxygen environments, or even nitrogen flushing are sometimes necessary, adding further costs.

3. Transportation

• Cold Chain Logistics: Transporting NAD requires cold chain logistics, meaning it must stay within a specific temperature range during transit to prevent degradation. This requires insulated packaging, cooling elements, and sometimes expedited shipping, all of which raise the shipping costs.

• Regulatory and Handling Fees: NAD for IV use is regulated, often requiring additional documentation, customs clearance (for international shipments), and specialized carriers trained to handle biological or temperature-sensitive materials.

These factors combined—the specialized nature of compounding, strict storage requirements, and the need for careful transportation—drive the cost of NAD therapy.
​

250mg NAD+ Infusion:

500mg NAD+ Infusion:

1000mg NAD+ Infusion:

What's more is we do not use lyophilized NAD. Our bio-fermented NAD+ has very high intracellular uptake and performance compared to lyophilized formats.
​

DripDok's offerings stand out due to the inclusion of home service, paid consultation (or no-consult curated protocols), personalized Myers cocktail, and follow-up with data analysis and baselining. These additional services enhance the overall value proposition and justify higher costs compared to providers who do not offer such extensive support.

​

In conclusion, DripDok's pricing for NAD+ IV infusions is competitive and offers substantial additional value through its comprehensive service package.
​
For patients who value convenience and personalized care, DripDok's offerings could be seen as cost-effective despite being on the higher end for some dosages.
​
​​